Related Experiment Video
Updated: Jun 20, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Prevention of venous thromboembolism in the cancer surgical patient
1Barts and London School of Medicine and Dentistry and Thrombosis Research Institute, London, United Kingdom. akkakkar@tri-london.ac.uk
Abstract:
Venous thromboembolism is a common complication in patients with malignant disease. One of the environments in which patients can present with symptomatic thromboembolic disease is in the postoperative period. Operation in the patient with cancer increases the risk of thromboembolic complications some two to three fold. A variety of methods have been evaluated for the prevention of thromboembolic disease in cancer surgical patients. The most extensively investigated are the pharmacologic methods, including low-dose unfractionated heparin and low molecular weight heparin. These agents are recommended for the prevention of thromboembolic disease during hospital stay. For selected high-risk populations, extended thromboprophylaxis into the postdischarge period is also recommended.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis I: Introduction
Aneurysm IV: Nursing Management